Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Greenfire Resources Announces Participation in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
-
WASTE MANAGEMENT TEAMSTERS RATIFY CONTRACT
-
Sapience Therapeutics to Showcase Clinical and Biomarker Data from ST101 Phase 2 Study in GBM at ASCO 2024
-
Aadi Bioscience Presents New Nonclinical Data Demonstrating Preferential Tumor Uptake of nab-Sirolimus at the American Society of Clinical Oncology (ASCO) Annual Meeting
-
Elicio Therapeutics Announces Preliminary Data from the Ongoing AMPLIFY-7P Phase 1a Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting
-
Power Integrations to Present at Upcoming Investor Conferences
-
Premier Health Reports 2024 Second Quarter Results
-
Titanium Transportation Group Declares Quarterly Dividend
-
ALT Stockholders: Robbins LLP Reminds ALT Stockholders of Securities Fraud Class Action Against Altimmune, Inc.
-
Community Bancorp. Re-Elects Directors and Discusses Strong 2023 and First Quarter 2024 Results at Annual Shareholders' Meeting
-
EDETEK Launches Continuous Study Monitoring Module for CONFORM™ Informatics
-
CXApp Inc. (Nasdaq: CXAI) Announces Record NRR Growth for Q1’24 & Launch of CXAI VU in collaboration with Google Cloud
-
MTTR Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Matterport to CoStar Group
-
MTTR Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Matterport to CoStar Group
-
SSR Mining Announces Voting Results From 2024 Annual and Special Meeting of Shareholders
-
Tiny Announces Annual General and Special Meeting of Shareholders
-
Pan American Silver Releases 2023 Sustainability Report
-
HRBR Stockholders: Robbins LLP Reminds HRBR Stockholders of Securities Fraud Class Action Against Harbor Diversified, Inc.
-
DOCS INVESTOR NEWS: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DOCS
-
Trailblazing Dragons' Den Star Named United Nations Association in Canada's 2024 Global Citizen Laureate
-
INTC Stockholders: Robbins LLP Reminds INTC Stockholders of Securities Fraud Class Action Against Intel Corporation
-
Graphic Packaging Holding Company Declares Quarterly Dividend
-
Crypto Specialist Bitwise’s First-Ever Spot Ethereum ETF Receives Key SEC Approval
-
Sailfish Reports Q1 2024 Results
-
Gesa Credit Union Announces Agreement to Acquire Security State Bank
-
EDETEK to Showcase "End-to-End Digital Data Pipeline for Clinical Trials" at AWS Healthcare and Life Sciences Meetup in Los Angeles, CA
-
Pei enters the MSCI COLCAP index
-
Fresh2 Group Ltd. Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq
-
Fresh2 Group Ltd. Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq
-
NextEra Energy board declares quarterly dividend
-
Oklo Partners with Wyoming Hyperscale to Deliver 100 Megawatts to its Data Centers
-
American Aires Extends Global Expansion by Opening Latest International Fulfillment Center in the UK
-
Deveron Announces Dates for Q3 2024 Earnings Release
-
Aurania Announces Closing of Tranche 2 of Private Placement
-
Avenix Fzco Introduces New Expert Advisor Pivozon for Enhanced Forex Trading on EURUSD
-
Puma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual Meeting
-
Flatiron Health Announces Research to Be Presented at American Society of Clinical Oncology 2024 Annual Meeting
-
PARAMOUNT GLOBAL AND CHARTER COMMUNICATIONS ANNOUNCE NEW MULTI-YEAR AGREEMENT FOR DISTRIBUTION OF PARAMOUNT'S LINEAR NETWORKS, CBS OWNED-AND-OPERATED STATIONS AND DIRECT-TO-CONSUMER STREAMING SERVICES
-
NW Natural Holdings and NW Natural CEO David H. Anderson Announces Retirement
-
Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-
SpringWorks Therapeutics Announces Data to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-
SILVERCORP REPORTS ADJUSTED NET INCOME OF $39.3 MILLION, $0.22 PER SHARE, AND CASH FLOW FROM OPERATIONS OF $91.6 MILLION FOR FISCAL 2024
-
Nimbus Therapeutics Presents New Positive Monotherapy Phase 1/2 Clinical Data of HPK1 Inhibitor in Treatment of Advanced Solid Tumors at 2024 ASCO Annual Meeting
-
Special Olympics Florida and Orlando Health Announce Five-Year Partnership
-
Extraordinary 80+ Acre Paradise Island, Boca Grande, FL, Hits Market After 70-Years: A Once-in-a-Lifetime Opportunity for Discerning Buyers
-
Sensei Biotherapeutics Presents Promising Clinical Data from Phase 1 Dose Escalation Study of SNS-101
-
Breakthrough Data on Botensilimab/Balstilimab in MSS CRC Presented at the 2024 ASCO Annual Meeting
-
Barnes & Noble Education Announces Preliminary Fiscal Year 2024 Results
-
Ivy Brain Tumor Center announces Phase 0/2 clinical readout of niraparib indicating significant improvement in overall survival of newly diagnosed glioblastoma patients
-
KinderCare Learning Companies Applauds Bipartisan Effort to Support Working Families through Child Care Access


